Meanwhile, patients with CHIP, represented by JAK2V617F mutation, had a 12.1-fold increase in cardiovascular diseases (CADs), while CHIP sustained by DNMT3A, TET2, or ASXL1 had a 1.7–2-fold increase in CADs (28). Here, TET2 is linked to cardiovascular disorder.